Skip to main content

Advertisement

Table 2 Safety of the study regimens

From: Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

  CC CP
  Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4
Anemia 30 6 38 5
Neutropenia 16 16 9 18
Thrombocytopenia 24 2 7 1
Fatigue 14 0 11 1
Myalgia 0 0 23 1
Anorexia 26 0 29 2
Nausea 21 1 18 1
Vomiting 8 1 4 0
Stomatitis 11 0 20 2
Diarrhea 8 1 11 1
Constipation 6 0 5 0
Neuropathy 13 0 26 0
Alopecia 1 0 10 0
Skin 15 0 16 1
Nail changes 6 0 8 0